11-110430130-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004109.5(FDX1):c.10G>T(p.Ala4Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000549 in 1,239,204 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004109.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FDX1 | NM_004109.5 | c.10G>T | p.Ala4Ser | missense_variant | 1/4 | ENST00000260270.3 | NP_004100.1 | |
FDX1 | XM_047426566.1 | c.8+777G>T | intron_variant | XP_047282522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FDX1 | ENST00000260270.3 | c.10G>T | p.Ala4Ser | missense_variant | 1/4 | 1 | NM_004109.5 | ENSP00000260270 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000257 AC: 39AN: 151864Hom.: 1 Cov.: 32
GnomAD4 exome AF: 0.0000267 AC: 29AN: 1087232Hom.: 0 Cov.: 30 AF XY: 0.0000269 AC XY: 14AN XY: 519590
GnomAD4 genome AF: 0.000257 AC: 39AN: 151972Hom.: 1 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.10G>T (p.A4S) alteration is located in exon 1 (coding exon 1) of the FDX1 gene. This alteration results from a G to T substitution at nucleotide position 10, causing the alanine (A) at amino acid position 4 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at